US Stock MarketDetailed Quotes

ALNY Alnylam Pharmaceuticals

Watchlist
  • 244.890
  • -1.910-0.77%
Close Nov 22 16:00 ET
  • 244.400
  • -0.490-0.20%
Post 20:01 ET
31.59BMarket Cap-93469P/E (TTM)

About Alnylam Pharmaceuticals Company

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference. The company was founded by Noble Laureate, David Bartel, Thomas Tuschl, Phillip Zamore, Paul R. Schimmel, and Phillip Allen Sharp on June 14, 2002 and is headquartered in Cambridge, MA.

Company Profile

SymbolALNY
Company NameAlnylam Pharmaceuticals
Listing DateMay 27, 2004
Issue Price6.00
Founded2002
CEODr. Yvonne L Greenstreet, MB.Ch.B.
MarketNASDAQ
Employees2100
Fiscal Year Ends12-31
Address675 West Kendall Street,Henri A. Termeer Square
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02142
Phone1-617-551-8200
Websitehttp://www.alnylam.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Yvonne L Greenstreet, MB.Ch.B.
  • Director and Chief Executive Officer
  • 8.90M
  • Tolga Tanguler
  • Chief Commercial Officer
  • 2.87M
  • Dr. Akshay K. Vaishnaw, M.D.,PhD
  • Chief Innovation Officer
  • 3.32M
  • Kevin Joseph Fitzgerald, PhD
  • Executive Vice President, Chief Scientific Officer and Head, Early Research and Early Development
  • --
  • Jeffrey V. Poulton
  • Executive Vice President, Chief Financial Officer and Principal Accounting Officer
  • 3.22M
  • Dr. Pushkal P. Garg, M.D.
  • Chief Medical Officer and Executive Vice President, Development and Medical Affairs
  • 3.23M
  • Amy W. Schulman
  • Chairman of the Board
  • 531.36K
  • Michael W. Bonney
  • Director
  • 467.23K
  • Dr. Olivier Raymond Brandicourt, M.D.
  • Independent Director
  • 480.96K
  • Dr. Carolyn R. Bertozzi, PhD
  • Independent Director
  • 668.94K
  • David E.I. Pyott, M.B.A.,M.D.
  • Independent Director
  • 477.21K
  • Dr. Dennis A. Ausiello, M.D.
  • Independent Director
  • 477.21K
  • Peter N. Kellogg
  • Independent Director
  • 658.72K
  • Dr. Phillip A. Sharp,PhD
  • Independent Director
  • 502.21K
  • Dr. Elliott Sigal, M.D.,PhD
  • Independent Director
  • 470.11K
  • Colleen F. Reitan
  • Independent Director
  • 489.15K
  • Dr. Margaret A. Hamburg, M.D.
  • Independent Director
  • 471.39K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data